Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment drug screens, Post-employment), By Product (Consumables), By Mode, By Drug, By End Use, By Region, And Segment Forecasts, 2025

The global employer and workplace drug testing market size was estimated at USD 6,105.1 million in 2024 and is projected to reach 9,089.9 million by 2033, growing at a CAGR of 4.6% from 2025 to 2033. This market focuses on detecting the presence of illicit drugs and controlled substances in biological samples to support workplace safety, regulatory compliance, and productivity.

Testing methods such as urine, oral fluid, hair, and blood analysis are widely used across industries, including transportation, manufacturing, construction, and energy, to reduce workplace accidents and absenteeism. Employer and workplace drug testing plays a significant role in pre-employment screening, random testing, and post-incident investigations, helping organizations maintain a safe and compliant workforce. The demand is driven by stricter government regulations, corporate policies promoting drug-free environments, and the availability of advanced rapid testing kits and laboratory-based confirmation methods. Growing awareness of substance abuse impacts on workforce performance and safety is further encouraging adoption across both developed and emerging markets.

According to a national survey by American Addiction Centers, 15.3% of U.S. workers reported working under the influence of alcohol, while 2.9% admitted to being under the influence of illicit drugs in 2024. These figures underscore a significant challenge for U.S. employers, highlighting the need for strong workplace drug testing policies. Furthermore, there is a growing emphasis on workplace safety and productivity, prompting organizations to adopt measures that ensure a drug-free environment. Rising awareness of the adverse effects of substance misuse in the workplace, including reduced productivity, increased absenteeism, workplace accidents, and legal liabilities, further drives demand for drug testing services.

Global Employer And Workplace Drug Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global employer and workplace drug testing market on the basis of type, product, mode, drug, end use, and region:

Type Outlook (Revenue, USD Million, 2021 - 2033)
Pre-employment drug screens
Post-employment
Product Outlook (Revenue, USD Million, 2021 - 2033)
Consumables
Instruments
Rapid Testing Devices
Services
Mode Outlook (Revenue, USD Million, 2021 - 2033)
Urine
Hair
Oral Fluid
Instant testing
Drug Outlook (Revenue, USD Million, 2021 - 2033)
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
IT/Finance
Manufacturing
Transportation
Construction
Retail and Hospitality
Healthcare
Education
Other Professional Services
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68040-463-5

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Type Segment
- 1.2.2. Product Segment
- 1.2.3. Mode Segment
- 1.2.4. Drug Segment
- 1.2.5. End-use Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Global Employer and Workplace Drug Testing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising demand for pre-employment testing
  - 3.2.1.2. Stringent laws mandating alcohol and drug testing in the workplace
  - 3.2.1.3. Rising prevalence of substance use in the workplace
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Changing legal environment and changing societal norms
- 3.2.3. Market opportunity analysis
  - 3.2.3.1. Technological advancement in drug testing for workplace
3.3. Global Employer and Workplace Drug Testing Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Global Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Employer and Workplace Drug Testing Market Type Movement Analysis
4.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by type, 2021 to 2033 (USD Million)
4.4. Pre-employment Drug Screens
- 4.4.1. Pre-employment drug screens market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Post-employment
- 4.5.1. Post-employment market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Employer and Workplace Drug Testing Market Product Movement Analysis
5.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
5.4. Consumables
- 5.4.1. Consumables market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Instruments
- 5.5.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Rapid Testing Devices
- 5.6.1. Rapid testing devices market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Services
- 5.7.1. Services market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Employer and Workplace Drug Testing Market Mode Movement Analysis
6.3. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by mode, 2021 to 2033 (USD Million)
6.4. Urine
- 6.4.1. Urine market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Hair
- 6.5.1. Hair market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Oral Fluid
- 6.6.1. Oral fluid market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Instant testing
- 6.7.1. Instant testing market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Global Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Employer and Workplace Drug Testing Market Drug Movement Analysis
- 7.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by drug, 2021 to 2033 (USD Million)
7.3. Alcohol
- 7.3.1. Alcohol market estimates and forecasts, 2021 to 2033 (USD Million)
7.4. Cannabis/Marijuana
- 7.4.1. Cannabis/marijuana market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Cocaine
- 7.5.1. Cocaine market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Opioids
- 7.6.1. Opioids testing market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Amphetamine & Methamphetamine
- 7.7.1. Amphetamine & methamphetamine market estimates and forecasts, 2021 to 2033 (USD Million)
7.8. LSD
- 7.8.1. LSD market estimates and forecasts, 2021 to 2033 (USD Million)
7.9. Others
- 7.9.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Global Employer and Workplace Drug Testing Market: End-use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Global Employer and Workplace Drug Testing Market End-use Movement Analysis
- 8.2.1. Global Employer and Workplace Drug Testing Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
8.3. IT/Finance
- 8.3.1. IT/finance market estimates and forecasts, 2021 to 2033 (USD Million)
8.4. Manufacturing
- 8.4.1. Manufacturing market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Transportation
- 8.5.1. Transportation market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Construction
- 8.6.1. Construction market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Retail and Hospitality
- 8.7.1. Retail and hospitality market estimates and forecasts, 2021 to 2033 (USD Million)
8.8. Healthcare
- 8.8.1. Healthcare market estimates and forecasts, 2021 to 2033 (USD Million)
8.9. Education
- 8.9.1. Education surgical centers market estimates and forecasts, 2021 to 2033 (USD Million)
8.10. Other Professional Services
- 8.10.1. Other Professional Services market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Employer and Workplace Drug Testing Market: Regional Estimates & Trend Analysis

9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.3. North America
- 9.3.1. U.S.
  - 9.3.1.1. Key country dynamics
  - 9.3.1.2. Regulatory framework/ reimbursement structure
  - 9.3.1.3. Competitive scenario
  - 9.3.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.3.2. Canada
  - 9.3.2.1. Key country dynamics
  - 9.3.2.2. Regulatory framework/ reimbursement structure
  - 9.3.2.3. Competitive scenario
  - 9.3.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.3.3. Mexico
  - 9.3.3.1. Key country dynamics
  - 9.3.3.2. Regulatory framework/ reimbursement structure
  - 9.3.3.3. Competitive scenario
  - 9.3.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
9.4. Europe
- 9.4.1. UK
  - 9.4.1.1. Key country dynamics
  - 9.4.1.2. Regulatory framework/ reimbursement structure
  - 9.4.1.3. Competitive scenario
  - 9.4.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.2. Germany
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Regulatory framework/ reimbursement structure
  - 9.4.2.3. Competitive scenario
  - 9.4.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.3. France
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Regulatory framework/ reimbursement structure
  - 9.4.3.3. Competitive scenario
  - 9.4.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.4. Italy
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. Regulatory framework/ reimbursement structure
  - 9.4.4.3. Competitive scenario
  - 9.4.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.5. Spain
  - 9.4.5.1. Key country dynamics
  - 9.4.5.2. Regulatory framework/ reimbursement structure
  - 9.4.5.3. Competitive scenario
  - 9.4.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.6. Norway
  - 9.4.6.1. Key country dynamics
  - 9.4.6.2. Regulatory framework/ reimbursement structure
  - 9.4.6.3. Competitive scenario
  - 9.4.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.7. Sweden
  - 9.4.7.1. Key country dynamics
  - 9.4.7.2. Regulatory framework/ reimbursement structure
  - 9.4.7.3. Competitive scenario
  - 9.4.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.4.8. Denmark
  - 9.4.8.1. Key country dynamics
  - 9.4.8.2. Regulatory framework/ reimbursement structure
  - 9.4.8.3. Competitive scenario
  - 9.4.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
9.5. Asia Pacific
- 9.5.1. Japan
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Regulatory framework/ reimbursement structure
  - 9.5.1.3. Competitive scenario
  - 9.5.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.5.2. China
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Regulatory framework/ reimbursement structure
  - 9.5.2.3. Competitive scenario
  - 9.5.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.5.3. India
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Regulatory framework/ reimbursement structure
  - 9.5.3.3. Competitive scenario
  - 9.5.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.5.4. Australia
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Regulatory framework/ reimbursement structure
  - 9.5.4.3. Competitive scenario
  - 9.5.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.5.5. South Korea
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Regulatory framework/ reimbursement structure
  - 9.5.5.3. Competitive scenario
  - 9.5.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.5.6. Thailand
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Regulatory framework/ reimbursement structure
  - 9.5.6.3. Competitive scenario
  - 9.5.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
9.6. Latin America
- 9.6.1. Brazil
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Regulatory framework/ reimbursement structure
  - 9.6.1.3. Competitive scenario
  - 9.6.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.6.2. Argentina
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Regulatory framework/ reimbursement structure
  - 9.6.2.3. Competitive scenario
  - 9.6.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
9.7. MEA
- 9.7.1. South Africa
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Regulatory framework/ reimbursement structure
  - 9.7.1.3. Competitive scenario
  - 9.7.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.7.2. Saudi Arabia
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Regulatory framework/ reimbursement structure
  - 9.7.2.3. Competitive scenario
  - 9.7.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.7.3. UAE
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Regulatory framework/ reimbursement structure
  - 9.7.3.3. Competitive scenario
  - 9.7.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 9.7.4. Kuwait
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Regulatory framework/ reimbursement structure
  - 9.7.4.3. Competitive scenario
  - 9.7.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2024
10.4. List of Key Certification Providers/Scheme Owners
10.5. Company Profiles/Listing
- 10.5.1. First Advantage
  - 10.5.1.1. Company overview
  - 10.5.1.2. Financial performance
  - 10.5.1.3. Product benchmarking
  - 10.5.1.4. Strategic initiatives
- 10.5.2. Laboratory Corporation of America Holdings (Labcorp)
  - 10.5.2.1. Company overview
  - 10.5.2.2. Financial performance
  - 10.5.2.3. Product benchmarking
  - 10.5.2.4. Strategic initiatives
- 10.5.3. Dragerwerk AG & Co. KGaA
  - 10.5.3.1. Company overview
  - 10.5.3.2. Financial performance
  - 10.5.3.3. Product benchmarking
  - 10.5.3.4. Strategic initiatives
- 10.5.4. Bio-Rad Laboratories, Inc.
  - 10.5.4.1. Company overview
  - 10.5.4.2. Financial performance
  - 10.5.4.3. Product benchmarking
  - 10.5.4.4. Strategic initiatives
- 10.5.5. Abbott
  - 10.5.5.1. Company overview
  - 10.5.5.2. Financial performance
  - 10.5.5.3. Product benchmarking
  - 10.5.5.4. Strategic initiatives
- 10.5.6. Clinical Reference Laboratory Inc.
  - 10.5.6.1. Company overview
  - 10.5.6.2. Financial performance
  - 10.5.6.3. Product benchmarking
  - 10.5.6.4. Strategic initiatives
- 10.5.7. Quest Diagnostics
  - 10.5.7.1. Company overview
  - 10.5.7.2. Financial performance
  - 10.5.7.3. Product benchmarking
  - 10.5.7.4. Strategic initiatives
- 10.5.8. Cordant Health Solutions
  - 10.5.8.1. Company overview
  - 10.5.8.2. Financial performance
  - 10.5.8.3. Product benchmarking
  - 10.5.8.4. Strategic initiatives
- 10.5.9. DISA Global Solutions
  - 10.5.9.1. Company overview
  - 10.5.9.2. Financial performance
  - 10.5.9.3. Product benchmarking
  - 10.5.9.4. Strategic initiatives
- 10.5.10. HireRight, LLC
  - 10.5.10.1. Company overview
  - 10.5.10.2. Financial performance
  - 10.5.10.3. Product benchmarking
  - 10.5.10.4. Strategic initiatives
- 10.5.11. OraSure Technologies, Inc.
  - 10.5.11.1. Company overview
  - 10.5.11.2. Financial performance
  - 10.5.11.3. Product benchmarking
  - 10.5.11.4. Strategic initiatives
- 10.5.12. Psychemedics Corporation
  - 10.5.12.1. Company overview
  - 10.5.12.2. Financial performance
  - 10.5.12.3. Product benchmarking
  - 10.5.12.4. Strategic initiatives
- 10.5.13. Omega Laboratories
  - 10.5.13.1. Company overview
  - 10.5.13.2. Financial performance
  - 10.5.13.3. Product benchmarking
  - 10.5.13.4. Strategic initiatives

Product Code: GVR-4-68040-463-5

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 U.S. employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 4 U.S. employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 5 U.S. employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 6 U.S. employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 7 U.S. employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 8 North America employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
Table 9 North America employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 10 North America employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 11 North America employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 12 North America employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 13 North America employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 14 Canada employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 15 Canada employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 16 Canada employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 17 Canada employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 18 Canada employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 19 Mexico employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 20 Mexico employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 21 Mexico employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 22 Mexico employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 23 Mexico employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 24 Europe employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
Table 25 Europe employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 26 Europe employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 27 Europe employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 28 Europe employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 29 Europe employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 30 UK employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 31 UK employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 32 UK employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 33 UK employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 34 UK employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 35 Germany employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 36 Germany employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 37 Germany employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 38 Germany employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 39 Germany employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 40 France employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 41 France employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 42 France employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 43 France employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 44 France employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 45 Italy employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 46 Italy employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 47 Italy employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 48 Italy employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 49 Italy employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 50 Spain employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 51 Spain employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 52 Spain employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 53 Spain employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 54 Spain employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 55 Denmark employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 56 Denmark employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 57 Denmark employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 58 Denmark employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 59 Denmark employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 60 Sweden employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 61 Sweden employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 62 Sweden employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 63 Sweden employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 64 Sweden employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 65 Norway employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 66 Norway employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 67 Norway employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 68 Norway employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 69 Norway employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 70 Asia Pacific employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
Table 71 Asia Pacific employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 72 Asia Pacific employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 73 Asia Pacific employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 74 Asia Pacific employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 75 Asia Pacific employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 76 Japan employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 77 Japan employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 78 Japan employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 79 Japan employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 80 Japan employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 81 China employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 82 China employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 83 China employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 84 China employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 85 China employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 86 India employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 87 India employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 88 India employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 89 India employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 90 India employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 91 Australia employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 92 Australia employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 93 Australia employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 94 Australia employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 95 Australia employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 96 South Korea employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 97 South Korea employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 98 South Korea employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 99 South Korea employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 100 South Korea employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 101 Thailand employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 102 Thailand employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 103 Thailand employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 104 Thailand employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 105 Thailand employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 106 Latin America employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
Table 107 Latin America employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 108 Latin America employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 109 Latin America employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 110 Latin America employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 111 Latin America employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 112 Brazil employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 113 Brazil employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 114 Brazil employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 115 Brazil employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 116 Brazil employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 117 Argentina employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 118 Argentina employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 119 Argentina employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 120 Argentina employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 121 Argentina employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 122 MEA employer and workplace drug testing market, by region, 2021 - 2033 (USD Million)
Table 123 MEA employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 124 MEA employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 125 MEA employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 126 MEA employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 127 MEA employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 128 South Africa employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 129 South Africa employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 130 South Africa employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 131 South Africa employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 132 South Africa employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 133 Saudi Arabia employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 134 Saudi Arabia employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 135 Saudi Arabia employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 136 Saudi Arabia employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 137 Saudi Arabia employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 138 UAE employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 139 UAE employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 140 UAE employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 141 UAE employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 142 global employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)
Table 143 Kuwait employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
Table 144 Kuwait employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
Table 145 Kuwait employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
Table 146 Kuwait employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
Table 147 Kuwait employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Global employer and workplace drug testing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter's five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Global employer and workplace drug testing market: Type outlook key takeaways
Fig. 20 Global employer and workplace drug testing market: Type movement analysis
Fig. 21 Pre-employment drug screens market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Post-employment market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Global employer and workplace drug testing market: Product outlook key takeaways
Fig. 24 Global employer and workplace drug testing market: Product movement analysis
Fig. 25 Consumables market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Rapid testing devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Global employer and workplace drug testing market: Mode outlook key takeaways
Fig. 30 Global employer and workplace drug testing market: Mode movement analysis
Fig. 31 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Hair market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Oral fluid market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Instant testing estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Global employer and workplace drug testing market: Mode outlook key takeaways
Fig. 36 Global employer and workplace drug testing market: Mode movement analysis
Fig. 37 Alcohol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Cannabis/marijuana market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Cocaine market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Opioids estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 LSD market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Global employer and workplace drug testing market: End-use outlook key takeaways
Fig. 45 Global employer and workplace drug testing market: End-use movement analysis
Fig. 46 IT/finance market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Construction estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Retail and hospitality market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Education market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Other professional services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Employer and Workplace Drug Testing Market: Regional outlook and key takeaways
Fig. 55 Regional outlook, 2024 & 2033
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 58 U.S. key country dynamics
Fig. 59 U.S. market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 60 Canada key country dynamics
Fig. 61 Canada market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 62 Europe
Fig. 63 Europe market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 64 UK key country dynamics
Fig. 65 UK market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 66 Germany
Fig. 67 Germany market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 68 France key country dynamics
Fig. 69 France market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 70 Italy key country dynamics
Fig. 71 Italy market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 72 Spain key country dynamics
Fig. 73 Spain market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 74 Denmark key country dynamics
Fig. 75 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 76 Sweden key country dynamics
Fig. 77 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 78 Norway key country dynamics
Fig. 79 Norway market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 80 Asia-Pacific
Fig. 81 Asia-Pacific market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 82 Japan key country dynamics
Fig. 83 Japan market estimates and forecast, 2021 - 2033(USD Million)
Fig. 84 China key country dynamics
Fig. 85 China market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 86 India key country dynamics
Fig. 87 India market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 88 South Korea key country dynamics
Fig. 89 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 90 Australia key country dynamics
Fig. 91 Australia market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 92 Thailand key country dynamics
Fig. 93 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 96 Brazil key country dynamics
Fig. 97 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 98 Mexico key country dynamics
Fig. 99 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 100 Argentina key country dynamics
Fig. 101 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 102 Middle East & Africa
Fig. 103 MEA market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 104 South Africa key country dynamics
Fig. 105 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 106 Saudi Arabia key country dynamics
Fig. 107 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 112 Market differentiators
Fig. 113 Key company market share analysis, 2024

Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment drug screens, Post-employment), By Product (Consumables), By Mode, By Drug, By End Use, By Region, And Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

Employer And Workplace Drug Testing Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Global Employer and Workplace Drug Testing Market Variables, Trends & Scope

Chapter 4. Global Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

Chapter 5. Global Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

Chapter 6. Global Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

Chapter 7. Global Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

Chapter 8. Global Employer and Workplace Drug Testing Market: End-use Estimates & Trend Analysis

Chapter 9. Employer and Workplace Drug Testing Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

List of Tables

List of Figures